GLP-1 Maker Accused of Bribing Docs; FDA Warns on Unapproved Meds; PFAS in Devices

By News Health
7 hours Ago

(MedPage Today) — In a lawsuit, Texas Attorney General Ken Paxton alleged that Eli Lilly bribed healthcare providers to prescribe its most profitable drugs, including the GLP-1 agonist tirzepatide (Mounjaro, Zepbound).
A 52-study meta-analysis…

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/116960

Author :

Publish date : 2025-08-12 19:29:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

The deadly cancers left behind by 50 years of success

DNA analysis reveals West African ancestry in early medieval England

Access Denied

Relying on AI in Colonoscopies May Erode Clinicians' Skills

Former FDA Chief Wants the Agency to Focus on Refined Carbohydrates

Serious Chronic Lung Disease Gets First FDA-Approved Drug